Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension.
about
Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular functionRole of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertensionEpoxyeicosatrienoic acids, hypertension, and kidney injuryCytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammationEpoxides and soluble epoxide hydrolase in cardiovascular physiologyGenome sequences of wild and domestic bactrian camelsAT1 receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyp1a1-Ren2 transgenic rats fed with a high-salt diet.Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.Modulation by salt intake of the vascular response mediated through adenosine A(2A) receptor: role of CYP epoxygenase and soluble epoxide hydrolase.Cyp2c44 epoxygenase in the collecting duct is essential for the high K+ intake-induced antihypertensive effect.Association of CYP2C19*2 and *3 genetic variants with essential hypertension in KoreansEndothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases.Gender-Specific Effect of CYP2C8*3 on the Risk of Essential Hypertension in Bulgarian Patients.An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertensionNOS 3 subcellular localization in the regulation of nitric oxide production.A novel vascular EET synthase: role of CYP2C7Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review.Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism.Eicosanoids and renal damage in cardiometabolic syndrome.Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease.Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused MiceChemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension.Failure to upregulate the adenosine2A receptor-epoxyeicosatrienoic acid pathway contributes to the development of hypertension in Dahl salt-sensitive rats.Radiation-induced afferent arteriolar endothelial-dependent dysfunction involves decreased epoxygenase metabolitesHigh-salt diet enhances mouse aortic relaxation through adenosine A2A receptor via CYP epoxygenases.Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive.Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.Renal medullary circulation.Salt modulates vascular response through adenosine A(2A) receptor in eNOS-null mice: role of CYP450 epoxygenase and soluble epoxide hydrolase.Cyp2c44 epoxygenase is essential for preventing the renal sodium absorption during increasing dietary potassium intake.Adenosine2A receptors and epoxyeicosatrienoic acids: a recipe for salt and blood pressure regulation.High-NaCl intake impairs dynamic autoregulation of renal blood flow in ANG II-infused rats.20-HETE or EETs: which arachidonic acid metabolite regulates proximal tubule transporters and contributes to pressure natriuresis?Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats.Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats.Diversity and distribution of CYP gene family in Bactrian camel.Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids.PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats.Adenosine inhibits ENaC via cytochrome P-450 epoxygenase-dependent metabolites of arachidonic acid.
P2860
Q26849271-0784AD4F-030D-4A90-85A8-735984F873CFQ27000348-9A9492F7-171A-409C-8918-D34C68987353Q28387823-8A370965-FB79-4A2C-90BE-7013654DC81EQ28393303-05779962-7FF9-48DC-B670-272B5279E674Q28396313-520B19A7-0106-4F10-A004-60C4DBF92933Q28710411-C9BF705F-D9FE-494B-8B9C-1F62867644F1Q33893353-954CC24E-04D4-43FA-91DD-2B788F9E0FBCQ33904690-8E62A02E-FC3D-488D-98A4-3014404AEB42Q33994992-75CB3726-4467-486E-8B0E-60EAAA3095F7Q34062858-17F425F9-CF9A-4E21-8351-4C83DC5FF57DQ34306561-33322114-8FCC-4FFB-B917-818DBD72B5DCQ34378817-265D91B2-E49D-4857-AA34-3F2642837CCDQ34442004-0F2D0B0D-2343-4B7D-8FA0-D92A8C6C7AA2Q34495642-C8085DBA-64D2-49F0-881E-3C3FE52A2698Q34557130-797EC4F8-725E-46AF-97D1-936043EF0A96Q35544096-294853F0-E521-4923-86AD-26407E41CF33Q35601565-E4A5014B-4A88-45AA-9021-F4A68004B7D9Q35637852-F1C3BF40-51CF-4C26-99E2-0889D3135333Q35849378-FD6E8B7F-F1EC-4FDA-AD00-2790E21B83B7Q35947602-B89925BC-DD3C-4696-B81C-A7E4FC721290Q35981986-6E6C35E9-0AB2-4B30-BB58-1D8882A85EAAQ36119361-174436BD-8DC3-41D9-946C-B03F289B260BQ36800161-67F89FDB-1A9F-4A8A-94E9-6A56F4DCB80FQ37018413-51D6065D-F63C-4EB5-B3F2-334AC59D3865Q37071883-6B6A8256-86F7-4FC6-AEB1-BA83F4F83CFAQ37151075-ABBD9C48-66FE-4231-ADA5-E2144B5EE847Q37462422-F932D008-A7BA-4E17-BDDD-E9F0EB2B67E8Q37960812-56F7E55D-B57C-4DE1-8E94-8F8D73C5D645Q38111278-182404C5-D291-4FFA-BDF7-FE27C9AB1F72Q42017195-3FA908A9-2589-4030-AC98-A62AB5BA2363Q42062684-708241A7-10CC-47BD-A432-60F00A673F42Q42671412-2D08D099-8A73-4BE4-8365-A05CBF9EB3B7Q42933571-2F470059-95C0-4052-B8C6-AE28371869CEQ44932438-A6112ECD-C81B-4EDF-8E70-8E430A2DB64CQ45042343-CFAB28D5-CEE1-4D20-A938-E50FC265F4C4Q45178533-37AA6309-51FB-4D5F-906A-DBB75DFC4179Q46307948-48B47B68-9F87-407E-9669-AAF5F10C658BQ46425681-AF6FE9B9-CFCD-456C-B2D0-A782A62B5F73Q46752310-7E7A1AFE-651C-45E4-804D-22484142B3E4Q46761419-44FEAC29-FB85-4499-AB4A-B22DCA651299
P2860
Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Decreased renal cytochrome P45 ...... n salt-sensitive hypertension.
@en
Decreased renal cytochrome P45 ...... n salt-sensitive hypertension.
@nl
type
label
Decreased renal cytochrome P45 ...... n salt-sensitive hypertension.
@en
Decreased renal cytochrome P45 ...... n salt-sensitive hypertension.
@nl
prefLabel
Decreased renal cytochrome P45 ...... n salt-sensitive hypertension.
@en
Decreased renal cytochrome P45 ...... n salt-sensitive hypertension.
@nl
P2093
P1433
P1476
Decreased renal cytochrome P45 ...... in salt-sensitive hypertension
@en
P2093
David M Pollock
Edward W Inscho
Xueying Zhao
P304
P356
10.1161/01.HYP.0000047877.36743.FA
P407
P433
P577
2002-12-16T00:00:00Z